RNART
DEAD

Serial Number

86119892

Owner

CUREVAC SE

Attorney

Jennifer Fraser

Filing Date

Nov 15, 2013

Add to watchlist:

No watchlists yet
View on USPTO

RNART Trademark

Serial Number: 86119892 • Registration: 4694261

RNART is a trademark filed by CUREVAC SE on November 15, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CUREVAC SE (14 trademarks)

FRIEDRICH-MIESCHER-STR. 15
TÜBINGEN 72076 , DE

Entity Type: 94

CUREVAC AG (20 trademarks)

PAUL-EHRLICH-STRASSE 15
TUEBINGEN 72076 , DE

Entity Type: 25

CureVac GmbH (13 trademarks)

Paul-Ehrlich-Str. 15
Tubingen 72076 , DE

Entity Type: 03

Trademark Details

Filing Date

November 15, 2013

Registration Date

March 3, 2015

Published for Opposition

December 16, 2014

Cancellation Date

September 19, 2025

Goods & Services

CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERINARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE

Chemical products and biomolecules, namely, biological macromolecules used for industrial and scientific purposes; reagents for research use

[ MEDICAL AND VETERINARY MEDICAL SERVICES, namely, THERAPEUTIC AND PREVENTIVE TREATMENT OF TUMORS, INFECTIOUS OR AUTOIMMUNE DISEASES AND ALLERGIES; TREATMENT OF HERITABLE DISEASES; MEDICAL SERVICES IN THE NATURE OF MEDICAL THERAPIES REPLACING PROTEINS OR ENZYMES; TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES; AND TREATMENT OF METABOLIC DISEASES ]

Scientific and technological services and research work, namely, the identification and characterization of biological macromolecules

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 19, 2025 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 3, 2024 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 8, 2023 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 10, 2021 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 10, 2021 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 10, 2021 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 1, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 3, 2020 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 12, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2018 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 23, 2016 ASGN
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 10, 2014 PREV
ASSIGNED TO LIE
Nov 4, 2014 ALIE
ASSIGNED TO LIE
Nov 4, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2014 CNSA
AMENDMENT FROM APPLICANT ENTERED
Sep 24, 2014 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 CRFA
ASSIGNED TO LIE
Sep 17, 2014 ALIE
PAPER RECEIVED
Sep 15, 2014 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2014 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2014 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2014 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2013 NWOS
NEW APPLICATION ENTERED
Nov 19, 2013 NWAP